Cargando…
Strategies for Liver Transplantation Tolerance
Liver transplant (LT) recipients require life-long immunosuppression (IS) therapy to preserve allograft function. The risks of chronic IS include an increased frequency of malignancy, infection, renal impairment, and other systemic toxicities. Despite advances in IS, long-term LT outcomes have not b...
Autores principales: | Cvetkovski, Filip, Hexham, J. Mark, Berglund, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956766/ https://www.ncbi.nlm.nih.gov/pubmed/33668238 http://dx.doi.org/10.3390/ijms22052253 |
Ejemplares similares
-
Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro
por: Binder, Christian, et al.
Publicado: (2020) -
Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity
por: Binder, Christian, et al.
Publicado: (2021) -
Contemporary Strategies and Barriers to Transplantation Tolerance
por: Ezekian, Brian, et al.
Publicado: (2018) -
Tolerance-Inducing Strategies in Islet Transplantation
por: Bhatt, Sumantha, et al.
Publicado: (2012) -
CD2 Immunobiology
por: Binder, Christian, et al.
Publicado: (2020)